Treace Medical Concepts/$TMCI
About Treace Medical Concepts
Ticker
Industry
Employees
TMCI Metrics
$637M
-
-$0.99
0.24
-
Price and volume
Market cap
$637M
Beta
0.24
52-week high
$15.44
52-week low
$3.92
Average daily volume
406K
Financial strength
Current ratio
4.119
Quick ratio
2.811
Long term debt to equity
66.458
Total debt to equity
66.842
Interest coverage (TTM)
-11.84%
Management effectiveness
Return on assets (TTM)
-17.13%
Return on equity (TTM)
-50.69%
Valuation
Price to revenue (TTM)
3.124
Price to book
6.07
Price to tangible book (TTM)
7.6
Price to free cash flow (TTM)
-14.673
Growth
Revenue change (TTM)
16.14%
Earnings per share change (TTM)
23.58%
3-year revenue growth (CAGR)
33.59%
3-year earnings per share growth (CAGR)
55.31%
What the Analysts think about TMCI
Analyst Ratings
TMCI Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
TMCI Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
TMCI News

Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Treace Medical Concepts, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm
What’s the current market cap for Treace Medical Concepts stock?
What is the P/E ratio for Treace Medical Concepts stock?
Does Treace Medical Concepts stock pay dividends?
No, Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders as of February 19, 2025.
When is the next Treace Medical Concepts dividend payment date?
Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders.
What is the beta indicator for Treace Medical Concepts?
Treace Medical Concepts (TMCI) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.